21 May 2009
Microvasculopathy does not predict coronary artery disease of the transplanted heart
M Zakliczyński, J Nożyński, D Konecka-Mrówka, Ł Pyka, D Trybunia, A Lekston, M Świerad, R Przybylski, M ZembalaAnn Transplant 2009; 14(1): 65-66 :: ID: 880439
Abstract
Background: A relation between microvasculopathy observed in endomyocardial biopsies (EMBs) and clinical coronary vasculopathy (CAV) after orthotopic heart transplantation (OHT) remains controversial. Aim of the study was to find a potential relation between microvasculopathy features in late EMBs and clinically confirmed CAV in long-term OHT survivors.
Material/Methods: We performed a retrospective analysis involving 68 pts. in
whom OHT was performed before 1999 - CAV (+) group consisted of 37 pts.
(35M/2F, 45±11y/o, ischemic c-pathy in 57%) with established CAV (need for coronary angioplasty, myocardial infarction or CAV-related death), control group was composed of 31 pts. (24M/7F, 43±16y/o, ischemic c-pathy in 39%) with negative coronary angiography 10 years after OHT. Microvasculopathy was assessed in elective EMBs performed 12 and 36 months after OHT using the following features: presence of prominent endothelial cells, degeneration of the endothelium, thickening of the muscle layer, thickening of the basal membrane, presence of lymphocytes in the arteriolar wall without any other signs of rejection vasculitis, periarteriolar fibrosis, and an occluded arteriolar lumen. Rejection grades in analyzed EMBs were comparable in both groups.
Results: The only significant difference was observed in occurrence of thickening of the basal membrane which was present in 22% of pts. from CMV (+) group and 3% of individuals from the control group. All other features, both in 12 and 36 month EMB, were similarly distributed (including basal membrane thickening 36 months after OHT).
Conclusions: Microvasculopathy observed 12 and 36 months after OHT is not predictive for CAV development.
Keywords: Heart Transplantation
In Press
06 May 2022 : Original article
Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...Ann Transplant In Press; DOI: 10.12659/AOT.936293
27 Apr 2022 : Review article
A Systematic Review of the Literature on Chronic Kidney Disease Following Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.935170
Most Viewed Current Articles
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Jul 2020 : Review article
Kidney Transplantation in the Times of COVID-19 – A Literature ReviewDOI :10.12659/AOT.925755
Ann Transplant 2020; 25:e925755
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860